Recall of Blood Thinner Product

by The Rothenberg Law Firm LLP
Contact

Alere Defective Medical Testing Strips Recalled

Are you currently taking a blood thinner to prevent the risk of a stroke, blood clot, or other medical condition?  A recent article in Forbes alerted patients that certain testing strips have been recalled because of their inaccuracy.  The article described the defective medical products as presenting an “exceptionally serious problem.”  What happens when testing strips are not accurate for patients on blood-thinning medications?  Patients reported having much higher INRs when tested by a laboratory than when using Alere’s INRatio2 PT/INR Professional Test Strips.

According to an FDA recall alert, Alere has “received nine serious adverse event reports, three of which described bleeding associated with patient deaths.”  What is an INR? INR stands for “international normalized ratio.”  While that might sound complicated, an INR basically indicates how likely a person’s blood is to clot by indicating the thickness of the blood.  For someone on a blood-thinning drug like warfarin (Coumadin) or blood-thinning heparin injection, the INR is an extremely important measurement.

How serious is the difference between the testing strip reads and those provided by a central laboratory? According to the article, Alere has learned that the strips can read “anywhere between 3.1 to 12.2 units lower than clinical laboratory results.”  As such, patients who rely on these testing strips could be in serious danger of “spontaneous bleeding.”  Indeed, three people have already sustained fatal injuries as a result of the defective product.

Alere is not sure what is causing the strips to give inaccurate INR readings.  The FDA has sent out an alert to patients who use the strips, and Alere has been “aggressively notifying patients and healthcare professionals about the problems with these strips.”

Anticoagulant Therapy Facts and Risks

What kind of people are prescribed anticoagulant or blood-thinning therapy?  Typically, patients who have had heart attacks, have irregular heartbeats, or have had certain kinds of heart surgeries may be prescribed warfarin or heparin injections.  Additionally, patients at risk of a blood clot—including those who have had blood clots or pulmonary embolisms—may also use blood-thinning therapy.  Specifically, the Mayo Clinic explains that you may be prescribed a blood-thinning drug if you meet one of the following conditions:

  • You had a blood clot that is in or near your ear, and as a result it could cause a stroke, heart attack, or serious organ damage;
  • You had pulmonary embolism (this is a blood clot in your lungs);
  • You had venous thrombosis (this is a blood clot somewhere in your body);
  • You have an arrhythmia;
  • You have a mechanical artificial heart valve; or
  • You have another risk factor for blood clots.

Warfarin is a generic name for the drugs more commonly known as Coumadin and Jantoven.  While warfarin can save the lives of those at risk of a deadly blood clot, it can also have a number of side effects.  These side effects can include but are not limited to the following:

  • Heavy and severe bleeding;
  • Rashes or hives;
  • Swelling around the face, mouth, and extremities;
  • Unexplained bruising;
  • Pain or pressure in your chest;
  • Nausea and vomiting;
  • Numbness in the body;
  • Fever and other flu-like symptoms; and
  • Necrosis.

Patients over the age of 75 are at particular risk of side effects when they are taking a blood-thinning medication.  It is important to be aware of the latest recalls related to blood thinning products.

Legal Recourse:

Medical product manufacturers have the responsibility of ensuring that all of their products are safe for use. In the event that you have been injured as a result of the recalled INR testing strips, you may be eligible to receive financial compensation for your injuries. It is important to discuss your situation with a defective medical products attorney who will help you determine your rights.

Alere Defective Medical Testing Strips Recalled

Are you currently taking a blood thinner to prevent the risk of a stroke, blood clot, or other medical condition?  A recent article in Forbes alerted patients that certain testing strips have been recalled because of their inaccuracy.  The article described the defective medical products as presenting an “exceptionally serious problem.”  What happens when testing strips are not accurate for patients on blood-thinning medications?  Patients reported having much higher INRs when tested by a laboratory than when using Alere’s INRatio2 PT/INR Professional Test Strips.

According to an FDA recall alert, Alere has “received nine serious adverse event reports, three of which described bleeding associated with patient deaths.”  What is an INR? INR stands for “international normalized ratio.”  While that might sound complicated, an INR basically indicates how likely a person’s blood is to clot by indicating the thickness of the blood.  For someone on a blood-thinning drug like warfarin (Coumadin) or blood-thinning heparin injection, the INR is an extremely important measurement.

How serious is the difference between the testing strip reads and those provided by a central laboratory?  According to the article, Alere has learned that the strips can read “anywhere between 3.1 to 12.2 units lower than clinical laboratory results.”  As such, patients who rely on these testing strips could be in serious danger of “spontaneous bleeding.”  Indeed, three people have already sustained fatal injuries as a result of the defective product.

Alere is not sure what is causing the strips to give inaccurate INR readings.  The FDA has sent out an alert to patients who use the strips, and Alere has been “aggressively notifying patients and healthcare professionals about the problems with these strips.”

Anticoagulant Therapy Facts and Risks

What kind of people are prescribed anticoagulant or blood-thinning therapy?  Typically, patients who have had heart attacks, have irregular heartbeats, or have had certain kinds of heart surgeries may be prescribed warfarin or heparin injections.  Additionally, patients at risk of a blood clot—including those who have had blood clots or pulmonary embolisms—may also use blood-thinning therapy.  Specifically, the Mayo Clinic explains that you may be prescribed a blood-thinning drug if you meet one of the following conditions:

  • You had a blood clot that is in or near your ear, and as a result it could cause a stroke, heart attack, or serious organ damage;
  • You had pulmonary embolism (this is a blood clot in your lungs);
  • You had venous thrombosis (this is a blood clot somewhere in your body);
  • You have an arrhythmia;
  • You have a mechanical artificial heart valve; or
  • You have another risk factor for blood clots.

Warfarin is a generic name for the drugs more commonly known as Coumadin and Jantoven.  While warfarin can save the lives of those at risk of a deadly blood clot, it can also have a number of side effects.  These side effects can include but are not limited to the following:

  • Heavy and severe bleeding;
  • Rashes or hives;
  • Swelling around the face, mouth, and extremities;
  • Unexplained bruising;
  • Pain or pressure in your chest;
  • Nausea and vomiting;
  • Numbness in the body;
  • Fever and other flu-like symptoms; and
  • Necrosis.

Patients over the age of 75 are at particular risk of side effects when they are taking a blood-thinning medication.  It is important to be aware of the latest recalls related to blood thinning products.

Legal Recourse:

Medical product manufacturers have the responsibility of ensuring that all of their products are safe for use. In the event that you have been injured as a result of the recalled INR testing strips, you may be eligible to receive financial compensation for your injuries. It is important to discuss your situation with a defective medical products attorney who will help you determine your rights.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© The Rothenberg Law Firm LLP | Attorney Advertising

Written by:

The Rothenberg Law Firm LLP
Contact
more
less

The Rothenberg Law Firm LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):
hide

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.

Security

JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at info@jdsupra.com. In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at: info@jdsupra.com.

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.
Feedback? Tell us what you think of the new jdsupra.com!